EMD-29824

Single-particle
4.0 Å
EMD-29824 Deposition: 17/02/2023
Map released: 15/11/2023
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-29824

Cryo-EM structure of RNP end 2

EMD-29824

Single-particle
4.0 Å
EMD-29824 Deposition: 17/02/2023
Map released: 15/11/2023
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: Complex of RNP end 2
Fitted models: 8g7u (Avg. Q-score: 0.379)
Raw data: EMPIAR-11494

Deposition Authors: Wang W , Pyle AM
The E3 ligase Riplet promotes RIG-I signaling independent of RIG-I oligomerization.
Wang W , Gotte B , Guo R, Pyle AM
(2023) Nat Commun , 14 , 7308 - 7308
PUBMED: 37951994
DOI: doi:10.1038/s41467-023-42982-0
ISSN: 2041-1723
Abstract:
RIG-I is an essential innate immune receptor that responds to infection by RNA viruses. The RIG-I signaling cascade is mediated by a series of post-translational modifications, the most important of which is ubiquitination of the RIG-I Caspase Recruitment Domains (CARDs) by E3 ligase Riplet. This is required for interaction between RIG-I and its downstream adapter protein MAVS, but the mechanism of action remains unclear. Here we show that Riplet is required for RIG-I signaling in the presence of both short and long dsRNAs, establishing that Riplet activation does not depend upon RIG-I filament formation on long dsRNAs. Likewise, quantitative Riplet-RIG-I affinity measurements establish that Riplet interacts with RIG-I regardless of whether the receptor is bound to RNA. To understand this, we solved high-resolution cryo-EM structures of RIG-I/RNA/Riplet complexes, revealing molecular interfaces that control Riplet-mediated activation and enabling the formulation of a unified model for the role of Riplet in signaling.